跳至主要内容
临床试验/NL-OMON37442
NL-OMON37442撤回不适用

Tumor- derived vesicles as Biomarkers for Ovarian cancer - TBO study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Material from 30 patients diagnosed with ovarian cancer and samples from 30 healthy volunteers will be collected. ;Inclusion criteria for the two groups;1. Patients with ovarian cancer: ;a. Diagnosed with epithelial ovarian cancer
  • b. > 18 years
  • c. Treatment in VUMC
  • d. Understanding of the Dutch or English language
  • e. Not using any medication
  • f. No thrombotic events in history
  • g. Written informed consent ;2. Healthy volunteers: ;a. > 18 years
  • b. Understanding of the Dutch or English language
  • c. Not using any medication
  • d. No malignancies in past
  • e. No thrombotic events in history
  • f. Written informed consent

排除标准

  • 1. Patients with ovarian cancer: ;a. < 18 years
  • b. No understanding of the Dutch or English language
  • c. Patients with history of malignancy other than that of ovarian cancer
  • d. Use of medication
  • e. Thrombotic events in history
  • f. No written informed consent ;2. Healthy volunteers: ;a. < 18 years
  • b. No understanding of the Dutch or English language
  • c. Use of medication
  • d. Malignancies in past
  • e. Thrombotic events in history
  • f. No written informed consent

研究者

相似试验